prostate biopsy
What is involved in the prostate biopsyprocedure?
prostate biopsy main points
Key Points:
Transperineal ultrasound-guided biopsy checks for prostate cancer.
No more reliable method for prostate examination than biopsies.
Common side effects include bleeding and reduced urinary flow. Infection is a rare occurrence.
Diagnosed prostate cancers may not be life-threatening. Some cases require no active treatment, only careful monitoring.
In selected cases, in-bore MRI-guided prostate biopsy is utilized.
This advanced technique enhances precision and diagnostic reliability in scenarios involving a large prostate and a small target.
surgery
What occurs on the day of the procedure?
A/Prof Homi Zargar will discuss the surgery once again to ensure your understanding and obtain your consent. An anaesthetist will meet with you to explore the options of a general or spinal anaesthetic and discuss post-procedure pain relief.
Details of the procedure:
Procedure is often performed under local anaesthesia, sometimes general or spinal needed.
Positioning in specialized supports for scrotum skin access.
Use of tape to reposition scrotum; prostate examined first.
Perineum cleaned with an antiseptic solution; local anaesthetic stinging may occur briefly.
Probe, about the width of a thumb, used for prostate biopsies.
Biopsy needles guided using an ultrasound scanner; additional guidance via MRI images.
The number of biopsies depends on PSA level, MRI report, and risk factors.
Procedure duration: 30 to 45 minutes; home within hours or 24 hours post-procedure.
A/Prof Homi Zargar is the pioneer of this technique in Victoria.
A/Prof Homi Zargar has conducted the most number of biopsies under local anaesthesia in the office setting.
Post-Biopsy Effects:
Blood in urine for up to 10 days - Almost all patients.
Blood in semen, lasting up to six weeks - Almost all patients.
Bruising and Discomfort:
Bruising in perineal area - Between 1 in 2 and 1 in 10 patients.
Discomfort in the prostate due to biopsy-related bruising - Between 1 in 2 and 1 in 10 patients.
Temporary erection problems from biopsy-related bruising - 1 in 20 patients (5%).
Urinary Issues:
Inability to pass urine (acute retention) - 1 in 20 patients (5%).
Bleeding in urine causing clot retention - 1 in 50 patients (2%).
Cancer Detection and Repeat Procedures:
Failure to detect significant prostate cancer - Between 1 in 10 and 1 in 50 patients.
Need for a repeat procedure for inconclusive biopsies or rising PSA - Between 1 in 10 and 1 in 50 patients.
Emergency Situations:
Bleeding in urine requiring emergency admission - 1 in 100 patients (1%).
Urine infection requiring antibiotics - 1 in 100 patients (1%).
Septicaemia (blood infection) requiring emergency admission - Less than 1 in 100 patients.